Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed)

Funding Opportunity RFA-AG-22-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will use the NIH Phased Innovation Award mechanism ((R21/R33) to develop novel transformative artificial intelligence/machine learning (AI/ML) strategies and computer automation to integrate, extract, and interpret multi-omic (i.e., genome, epigenome, transcriptome, proteome, metabolome, microbiome, phenome) data sets from human exceptional longevity (EL) cohorts and multiple non-human species that display wide variation in life span and decipher the relationships between DNA, RNA, proteins, metabolites, and other cell variables, as well as links to disease risks and exceptionally healthy aging.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding